As of August 28, 2023, South Koreans in their twenties had the highest coronavirus (COVID-19) vaccination rate in South Korea for the initial two shots, at 99.8 percent and 98.9 percent respectively. All adult age groups reported very high vaccination rates. Winter booster shot rates however were much lower across all age groups, though older age groups were more likely to have gotten them. Only around 13 percent of people nationwide have been vaccinated with a bivalent winter booster, which is more effective against current dominant strains. These shots were only offered in the winter of 2022.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

As of August 28, 2023, the province of Jeonnam (South Jeolla Province) had the highest coronavirus (COVID-19) vaccination rate in South Korea for all available vaccines. While 90 percent of people in Jeonnam got the first COVID-19 shot, the national vaccination rate lies below that, at 87.5 percent. Only 14.1 percent of people nationwide have been vaccinated with a bivalent booster, which is more effective against current dominant strains. These shots were only offered in the winter of 2022. A total of six provinces have higher vaccination rates than the national average, including the capital city of Seoul.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

The number of COVID-19 vaccination doses administered per 100 people in South Korea rose to 250 as of Oct 27 2023. This dataset includes a chart with historical data for South Korea Coronavirus Vaccination Rate.

North Korea Coronavirus COVID-19 Vaccination Rate - values, historical data, forecasts and news - updated on November of 2025.

The immunisation of influenza in South Korea increased by *** percent of population aged 65 years or over (+*** percent) in 2022. In total, the immunisation amounted to **** percent of population aged 65 years or over in 2022. This increase was preceded by a declining immunisation in this industry.Find more statistics on other topics about South Korea with key insights such as number of caesarian sections performed and share of children immunized against measles.

According to a survey conducted in 2021, around **** percent of South Korean students stated they were willing to get vaccinated against the coronavirus (COVID-19). Roughly ** percent were unsure, while the rest did not want to receive the vaccine. Children between the ages of 12 and 17 years have been able to get vaccinated as of October 5, 2021 in South Korea.

Even though they are important determinants for increasing vaccination rates in advanced and developing nations alike, maternal capacity and decisional authority have not been fully elucidated in diverse countries and cultural spheres. This study examined the effects of South Korean, Chinese, and Japanese mothers’ health literacy, self-efficacy, mass media use, and decisional authority on their children’s vaccination after adjustment for their socioeconomic statuses. Computer-assisted web interviews were conducted with married women in their 20s-40s of South Korean, Chinese, or Japanese nationality (n = 1,571). Dependent variables were generated for the following four vaccinations: BCG, diphtheria+pertussis+tetanus (DPT), poliomyelitis (polio), and measles. For statistical processing, cases where all four types of vaccines had been recorded were scored as 1 and other cases were processed as 0. According to the results of the pooled model, we found that for East Asian mothers, decisional authority, self-efficacy, and health literacy all increased the likelihood that they would vaccinate their children. Furthermore, women who searched for health information through media such as the radio were more likely to vaccinate their children. However, when elaborate analyses were conducted by country, there were considerable differences in those characteristics by country. Therefore, this study showed that it is necessary to establish locally tailored strategies in order to raise vaccination rates in the Global Vaccine Action Plan. This study also showed that social contexts must be taken into consideration in order to raise vaccination rates.

As of October 27, 2022, around 131.8 million coronavirus (COVID-19) vaccinations were recorded in South Korea. At the beginning of the vaccination campaign, the Korean government announced a COVID-19 vaccination plan for employees under the age of 65 in nursing hospitals or facilities, high-risk medical institutions, and the first responding group including emergency personnel or quarantine personnel, etc. The AstraZeneca vaccine was to be used for this priority group and the vaccination was scheduled to take place from February until May. Furthermore, vaccinations were planned for staff in hospitals treating COVID-19 patients, and the Pfizer vaccine was to be used for this group. South Korea's handling of the coronavirus (COVID-19) was initially widely praised, though the government's handling of vaccine distribution has been criticized.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

IntroductionWe evaluated the cost-effectiveness of South Korea’s planned annual coronavirus disease 2019 (COVID-19) booster campaign scheduled for October 2023.Materials and methodsAn age-structured mathematical model was used to analyze the public impacts and cost-effectiveness of vaccination across three vaccination strategies: uniform allocation and prioritizing those over 65 or those over 50 years old. We calculated the incremental cost per quality-adjusted life year (QALY) from both healthcare and societal perspectives. The maximum vaccine cost for cost-effectiveness was also identified.ResultsOur analysis highlights the cost-effectiveness of South Korea’s annual COVID-19 vaccination program in mitigating health and economic impacts. The most cost-effective strategy is uniform vaccine allocation, offering the lowest incremental cost-effectiveness ratio (ICER) at US$ 25,787/QALY. However, with a relatively high attack rate, the strategy prioritizing individuals over 65 years emerges as more cost-effective, lowering the ICER to US$ 13,785/QALY. Prioritizing those over 50 was less cost-effective. All strategies were cost-saving from a societal perspective, with cost-effectiveness being more sensitive to vaccine price than to its effectiveness.DiscussionOur results imply a potential strategy shift in current vaccination plan, with uniform vaccine distribution being more cost-effective than prioritizing older adults. Early estimation of viral transmissibility and vaccine effectiveness is crucial in determining the most cost-effective vaccine allocation approach.

Korea Immunization: DPT: % of Children Aged 12-23 Months data was reported at 98.000 % in 2016. This stayed constant from the previous number of 98.000 % for 2015. Korea Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 90.500 % from Dec 1981 (Median) to 2016, with 36 observations. The data reached an all-time high of 99.000 % in 2014 and a record low of 57.000 % in 1987. Korea Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Korea – Table KR.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Context

The COVID-19 outbreak has brought the whole planet to its knees.More over 4.5 million people have died since the writing of this notebook, and the only acceptable way out of the disaster is to vaccinate all parts of society. Despite the fact that the benefits of vaccination have been proved to the world many times, anti-vaccine groups are springing up all over the world. This data set was generated to investigate the impact of coronavirus vaccinations on coronavirus mortality.

Content

Data Collection

This dataset is a combination of the following three datasets:

1.https://www.kaggle.com/gpreda/covid-world-vaccination-progress

2.https://covid19.who.int/WHO-COVID-19-global-data.csv

3.https://www.kaggle.com/rsrishav/world-population

you can find more detail about this dataset by reading this notebook:

https://www.kaggle.com/sinakaraji/simple-linear-regression-covid-vaccination

Countries in this dataset:

Although the primary and secondary vaccination rates in Korea account for over 75% of the total population, confirmed cases of COVID-19 are dramatically increasing due to immune waning and the Omicron variant. Therefore, it is urgent to evaluate the effectiveness of booster vaccination strategies for living with COVID-19. In this work, we have developed an age-specific mathematical model with eight age groups and included age-specific comorbidities to evaluate the effectiveness of age-specific vaccination prioritization strategies to minimize morbidity and mortality. Furthermore, we have investigated the impacts of age-specific vaccination strategies for different vaccine supplies and non-pharmaceutical intervention levels during two periods: (1) when vaccine supply was insufficient and (2) after the emergence of the omicron variant. During the first period, the best option was to vaccinate the 30–49 year age group and the group with comorbidities to minimize morbidity and mortality, respectively. However, a booster vaccination should prioritize the 30–49 year age group to promote both minimal morbidity and mortality. Critical factors, such as vaccination speed, vaccine efficacy, and non-pharmaceutical interventions (NPIs), should be considered for effective vaccination prioritization as well. Primary, secondary vaccinations, and a booster shot vaccinations require different age prioritization strategies under different vaccination rates, vaccine efficacies, and NPI levels.

As of August 28, 2023, confirmed coronavirus (COVID-19) patients in their forties made up the largest share of patients in South Korea, amounting to around 15.2 percent of all positive cases. The first wave lasted until April, with the second wave following in August of 2020. This was further followed by a fourth wave, driven by the delta and omicron variants. Though the country has since achieved high vaccination rates, the omicron variant led to record new daily cases in 2022.

Patient profile

In South Korea, the infection rate of coronavirus was the highest among people in the twenties due to their social activities. Indeed, the new infections related to the clubgoers in Seoul are likely to increase the infection rate between young people. 158 out of 261 clubgoer-related confirmed patients were in teenagers or in their twenties, and 36 patients were in their thirties. The mortality rate of coronavirus by age group was somewhat different from the age distribution of total infection cases. It was highest among people in their eighties, with this group making up around 59.6 percent of deaths related to the coronavirus in South Korea. Mortality declined with each younger age group.

Daily life changes

In South Korea, a new policy of "With Corona" has been launched in order to ease society back into a new norm of living with the virus, without having too many restrictions in place. This is based on high vaccination rates, and includes strict quarantine measures for those who are infected and their close contacts. There are plans to improve the verification of vaccination and test certificates for use in public spaces. Most South Koreans have responded to rising numbers by once again avoiding crowded places or going out. It is common to wear masks regardless of diseases, so people are continuing to wear masks when they need to go out. Also, people prefer to do online shopping than physical shopping, and online sales of food and health-related products have increased by more than 700 percent compared to last year. Spending on living, cooking, and furniture has increased significantly as people spend more time at home.

Time series data for the statistic Immunization, measles (% of children ages 12-23 months) and country Korea, Rep.. Indicator Definition:Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.The indicator "Immunization, measles (% of children ages 12-23 months)" stands at 97.00 as of 12/31/2024. Regarding the One-Year-Change of the series, the current value is equal to the value the year prior.The 1 year change in percent is 0.0.The 3 year change in percent is -1.02.The 5 year change in percent is -1.02.The 10 year change in percent is -2.02.The Serie's long term average value is 85.91. It's latest available value, on 12/31/2024, is 12.91 percent higher, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/1980, to it's latest available value, on 12/31/2024, is +2,325.00%.The Serie's change in percent from it's maximum value, on 12/31/2004, to it's latest available value, on 12/31/2024, is -2.02%.

Influenza vaccination rates and sociodemographic factors in target groups.

Korea Immunization: HepB3: % of One-Year-Old Children data was reported at 98.000 % in 2016. This stayed constant from the previous number of 98.000 % for 2015. Korea Immunization: HepB3: % of One-Year-Old Children data is updated yearly, averaging 94.000 % from Dec 1995 (Median) to 2016, with 22 observations. The data reached an all-time high of 99.000 % in 2014 and a record low of 82.000 % in 1998. Korea Immunization: HepB3: % of One-Year-Old Children data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Korea – Table KR.World Bank: Health Statistics. Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Actual value and historical data chart for South Korea Immunization Hib3 Percent Of Children Ages 12 23 Months

The average for 2022 based on 187 countries was 84 percent. The highest value was in Antigua and Barbuda: 99 percent and the lowest value was in North Korea: 0 percent. The indicator is available from 1980 to 2022. Below is a chart for all countries where data are available.

Actual value and historical data chart for South Korea Immunization Dpt Percent Of Children Ages 12 23 Months

IntroductionDespite vaccine development, the COVID-19 pandemic is ongoing due to immunity-escaping variants of concern (VOCs). Estimations of vaccine-induced protective immunity against VOCs are essential for setting proper COVID-19 vaccination policy.MethodsWe performed plaque-reduction neutralizing tests (PRNTs) using sera from healthcare workers (HCWs) collected from baseline to six months after COVID-19 vaccination and from convalescent COVID-19 patients. The 20.2% of the mean PRNT titer of convalescent sera was used as 50% protective value, and the percentage of HCWs with protective immunity for each week (percent-week) was compared among vaccination groups. A correlation equation was deduced between a PRNT 50% neutralizing dose (ND50) against wild type (WT) SARS-CoV-2 and that of the Delta variant.ResultsWe conducted PRNTs on 1,287 serum samples from 297 HCWs (99 HCWs who received homologous ChAdOx1 vaccination (ChAd), 99 from HCWs who received homologous BNT162b2 (BNT), and 99 from HCWs who received heterologous ChAd followed by BNT (ChAd-BNT)). Using 365 serum samples from 116 convalescent COVID-19 patients, PRNT ND50 of 118.25 was derived as 50% protective value. The 6-month cumulative percentage of HCWs with protective immunity against WT SARS-CoV-2 was highest in the BNT group (2297.0 percent-week), followed by the ChAd-BNT (1576.8) and ChAd (1403.0) groups. In the inter-group comparison, protective percentage of the BNT group (median 96.0%, IQR 91.2–99.2%) was comparable to the ChAd-BNT group (median 85.4%, IQR 15.7–100%; P =0.117) and significantly higher than the ChAd group (median 60.1%, IQR 20.0–87.1%; P <0.001). When Delta PRNT was estimated using the correlation equation, protective immunity at the 6-month waning point was markedly decreased (28.3% for ChAd group, 52.5% for BNT, and 66.7% for ChAd-BNT).ConclusionDecreased vaccine-induced protective immunity at the 6-month waning point and lesser response against the Delta variant may explain the Delta-dominated outbreak of late 2021. Follow-up studies for newly-emerging VOCs would also be needed.